D3S-001

CAT:
931-T89626-01
Size:
10 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
D3S-001 - image 1

D3S-001

  • Target:

    Ras|||Kras
  • Related Pathways:

    MAPK
  • Bioactivity:

    D3S-001 is an orally effective KRAS inhibitor. It suppresses the proliferation of the KRASG12C mutants H358 and MIA-PA-CA-2 with IC50 values of 0.6 and 0.44 nM, respectively. D3S-001 exhibits good metabolic stability across multiple species in hepatocytes, liver microsomes, plasma, and whole blood. Additionally, it demonstrates favorable pharmacokinetic properties and antitumor activity in mice.
  • Smiles:

    C (OC1=NC (=C2C (=N1) C[C@H] (OC2) C3=C (C (F) (F) F) C (C) =CC (N) =C3F) N4C[C@H] (CC#N) N (C (C (=C) F) =O) CC4) [C@@]56N (C[C@H] (F) C5) CCC6
  • Molecular Formula:

    C32H35F6N7O3
  • Molecular Weight:

    679.66
  • Shipping Conditions:

    Cool pack
  • Storage Temperature:

    -20°C
  • CAS Number:

    2914919-85-8